MTOR and sarcoidosis: metabolic alterations in monocytes have been identified as another hallmark, PBMCs from sarcoidosis patients show dysregulation of metabolic and oxidative phosphorylation pathways, particularly upregulation of the mechanistic target of rapamycin (mTOR) signaling pathway (45).